Genetic counselling and testing for susceptibility to breast, ovarian and colon cancer: where are we today?
Recent advances in our understanding of the genetic characteristics of cancer will change approaches to genetic screening and counselling. Cancer results from multiple, cumulative mutations in genes that regulate cell replication and differentiation. In familial cancer a germ-line mutation is passed on in an autosomal dominant pattern, but cancer will develop in people who inherit the defect only if other mutations also occur in susceptible somatic cells. The tumour-suppressor gene known as BRCA1 is thought to affect half of those families who have an inherited breast cancer syndrome and most families with a breast and ovarian cancer syndrome. Another gene, BRCA2, is thought to affect most of the remaining families with a breast-cancer-only syndrome. Hereditary nonpolyposis colon cancer (HNPCC) is caused by mutations in surveillance genes that protect DNA from the spontaneous errors that occur during cell division. Because there are no outcome data on which to base practice guidelines for genetic screening or management of asymptomatic carriers in families at risk, testing should be restricted to research settings.
Department of Clinical Biochemistry, University of Toronto, Ont.
D E
DE
Cole
S
S
Gallinger
D R
DR
McCready
B
B
Rosen
J
J
Engel
D
D
Malkin
D001943:Breast Neoplasms / Q000235:genetics* / Q000517:prevention & control*; D003110:Colonic Neoplasms / Q000235:genetics* / Q000517:prevention & control*; D004198:Disease Susceptibility / Q000175:diagnosis; D005260:Female; D005817:Genetic Counseling / Q000639:trends; D020022:Genetic Predisposition to Disease; D005820:Genetic Testing / Q000639:trends; D006801:Humans; D008297:Male; D009154:Mutation; D010051:Ovarian Neoplasms / Q000235:genetics* / Q000517:prevention & control*